Insiders · Profile

Koppikar Utpal

Chief Financial Officer at Atara Biotherapeutics · Director at C4 Therapeutics. Filing since 27 Jul 2018. CIK 0001742696

Company
Date
Role
Action
Shares
Amount
Of holding
2 Mar 2023
Chief Financial Officer
Sold, plan not stated
6,871
$24.92K
3.6%
8 Feb 2023
Director
Bought
5,667
$31.74K
opened
7 Feb 2023
Chief Financial Officer
Sold, plan not stated
2,485
$13.57K
1.3%
16 Nov 2022
Chief Financial Officer
Sold, plan not stated
6,255
$28.09K
3.2%
16 Aug 2022
Chief Financial Officer
Sold, plan not stated
5,940
$29.91K
2.9%
8 Jun 2022
Chief Financial Officer
Sold, plan not stated
5,853
$32.95K
2.8%
17 May 2022
Chief Financial Officer
Sold, plan not stated
5,582
$29.67K
2.6%
1 Mar 2022
Chief Financial Officer
Sold, plan not stated
3,763
$37.09K
1.7%
7 Feb 2022
Chief Financial Officer
Sold, plan not stated
2,496
$36.10K
1.6%
16 Nov 2021
Chief Financial Officer
Sold, plan not stated
3,655
$62.56K
2.3%
17 Aug 2021
Chief Financial Officer
Sold, plan not stated
3,579
$44.85K
2.2%
8 Jun 2021
Chief Financial Officer
Sold, plan not stated
5,820
$81.83K
3.4%
18 May 2021
Chief Financial Officer
Sold, plan not stated
3,616
$52.61K
2.1%
26 Mar 2021
Chief Financial Officer
Sold, plan not stated
1,761
$25.68K
1.0%
2 Mar 2021
Chief Financial Officer
Sold, plan not stated
1,461
$24.46K
0.8%
8 Feb 2021
Chief Financial Officer
Sold, plan not stated
1,759
$35.87K
1.3%
17 Nov 2020
Chief Financial Officer
Sold, plan not stated
1,469
$29.05K
1.1%
18 Aug 2020
Chief Financial Officer
Sold, plan not stated
1,496
$18.09K
1.1%
9 Jun 2020
Chief Financial Officer
Sold, plan not stated
3,924
$39.95K
2.8%
18 May 2020
Chief Financial Officer
Sold, plan not stated
1,428
$16.02K
1.0%
27 Mar 2020
Chief Financial Officer
Sold, plan not stated
1,827
$16.75K
1.3%
6 Feb 2020
Chief Financial Officer
Sold, plan not stated
1,781
$25.31K
2.4%
27 Jul 2018
Chief Financial Officer
Bought
2,000
$73.60K
4.4%
23 decisions on file.